MaskIT LLC founder and chief executive officer Shallan Ramsey was featured on the E! television show “Modern Living with Kathy Ireland.” The feminine care company said the segment focused on the socially responsible disposal of feminine hygiene products.
IMS Health and Quintiles have combined to form a new global health care information and service provider, QuintilesIMS. The companies on Monday said they have completed their merger, an all-stock merger-of-equals transaction announced in May. The agreement united IMS Health Holdings, Inc.
Coty Inc. has finalized its acquisition of the fine fragrances, salon professional, cosmetics, retail hair color, and select hair styling businesses of Procter & Gamble Co.
The Food and Drug Administration has issued a warning that homeopathic teething tablets and gels may present a health risk to infants and children. The FDA on Friday urged consumers to stop using the products and dispose of any that they have.
Sanofi has appointed former Bayer executive Alan Main as executive vice president of its newly formed Consumer HealthCare global business unit.
Brian McNamara has been promoted to chief executive officer of GlaxoSmithKline plc’s consumer health business. GSK said McNamara assumes the GSK Consumer Healthcare CEO post and joins GSK’s corporate executive team effective immediately.
Pampers has unveiled its smallest premature baby diaper using a design developed with neonatal intensive care unit (NICU) nurses.
Camber Pharmaceuticals has launched duloxetine 20-, 30- and 60-mg capsules, a medication for depression and anxiety. Camber said Tuesday that its product, a generic version of Cymbalta capsules from Eli Lilly and Co.
Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology.
Jon Giacomin, chief executive officer of the pharmaceutical segment at Cardinal Health Inc., has been elected as chairman of the Healthcare Distribution Alliance (HDA) board of directors.
Janssen Biotech Inc. has received Food and Drug Administration clearance for Stelara in treating Crohn’s disease in adults.
K-Y has expanded its sexual wellness product lineup with the launch of new K-Y Duration Spray for Men.
Endo International plc has appointed Paul Campanelli, as president and chief executive officer, succeeding Rajiv De Silva, who is stepping down. Endo said Campanelli, who was president of its generic drugs and OTC business, takes the helm as president and CEO effective immediately.
McKesson Pharmacy Systems has released Pharmaserv 7.5, the latest version of its independent pharmacy management software, for general availability.
Aurobindo Pharma Ltd. has gained tentative approval from the Food and Drug Administration for dolutegravir 50 mg, an HIV medication.
